Tatsuhiro Sato

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

New anti-mesothelioma compounds, paramyfurans and paramylactone, produced by Paramyrothecium sp. BF-1049.

New anti-mesothelioma compounds, paramyfurans and paramylactone, produced by Paramyrothecium sp. BF-1049.

Journal: The Journal of antibiotics
Published: February 02, 2026

Epithelioid Mesothelioma Cells Exhibit Increased Ferroptosis Sensitivity Compared to Non-Epithelioid Mesothelioma Cells.

Epithelioid Mesothelioma Cells Exhibit Increased Ferroptosis Sensitivity Compared to Non-Epithelioid Mesothelioma Cells.

Journal: Cancers
Published: November 10, 2025

Hydrogen-rich water improves endurance by reducing skeletal muscle oxidative stress and inflammatory responses.

Hydrogen-rich water improves endurance by reducing skeletal muscle oxidative stress and inflammatory responses.

Journal: Frontiers in nutrition
Published: October 10, 2025

Enhanced nuclear export caused by O-GlcNAcylation of nucleoporins is a potential therapeutic target in mesothelioma.

Enhanced nuclear export caused by O-GlcNAcylation of nucleoporins is a potential therapeutic target in mesothelioma.

Journal: British journal of cancer
Published: June 30, 2025

Intestinal epithelial cell-specific restoration of Nrf2 gene in whole-body-knockout mice ameliorates acute colitis.

Intestinal epithelial cell-specific restoration of Nrf2 gene in whole-body-knockout mice ameliorates acute colitis.

Journal: Experimental animals
Published: January 26, 2025

PBK Expression Promotes the Aggressive Phenotypes of Mesothelioma.

PBK Expression Promotes the Aggressive Phenotypes of Mesothelioma.

Journal: Cancer science
Published: November 06, 2024

TEAD-Independent Cell Growth of Hippo-Inactive Mesothelioma Cells: Unveiling Resistance to TEAD Inhibitor K-975 through MYC Signaling Activation.

TEAD-Independent Cell Growth of Hippo-Inactive Mesothelioma Cells: Unveiling Resistance to TEAD Inhibitor K-975 through MYC Signaling Activation.

Journal: Molecular cancer therapeutics
Published: May 01, 2024

NF2 alteration in mesothelioma.

NF2 alteration in mesothelioma.

Journal: Frontiers in toxicology
Published: March 01, 2023

Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations.

Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations.

Journal: Cancer medicine
Published: January 25, 2023

SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma.

SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma.

Journal: Cell death discovery
Published: July 19, 2022

Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively.

Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively.

Journal: Cancer cell international
Published: July 12, 2021

Oxytocin receptor is a promising therapeutic target of malignant mesothelioma.

Oxytocin receptor is a promising therapeutic target of malignant mesothelioma.

Journal: Cancer science
Published: February 22, 2021
Showing 1-12 of 22

Last Updated: 09/26/2026